Funder
National Institute of Health
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Lin X, Li H. Obesity: epidemiology, pathophysiology, and therapeutics. Front Endocrinol (Lausanne). 2021;12:706978. https://doi.org/10.3389/fendo.2021.706978.
2. Debédat J, Clément K, Aron-Wisnewsky J. Gut microbiota dysbiosis in human obesity: impact of bariatric surgery. Curr Obes Rep. 2019;8(3):229–42. https://doi.org/10.1007/s13679-019-00351-3.
3. Seeras K, Acho RJ, Lopez PP. Roux-en-Y gastric bypass chronic complications. In: StatPearls [Internet]. StatPearls Publishing; 2023. Accessed January 30, 2024. https://www.ncbi.nlm.nih.gov/books/NBK519489/
4. Dhir A, Huang D. Gut microbiome and bariatric surgery. Indian J Surg. 2021;83(2):395–7. https://doi.org/10.1007/s12262-021-02927-7.
5. Maciejewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 2016;151(11):1046–55. https://doi.org/10.1001/jamasurg.2016.2317.